The NYKET Center Europe is the first clinic in Europe to provide ketamine infusion services to people with treatment-resistant depression. Breakthrough ketamine treatments have shown to be effective for treatment-resistant conditions and the medical center helps people overcome their symptoms one infusion at a time. Conditions they treat include fibromyalgia, migraines, and complex regional pain syndrome.
Ready to explore a new horizon in mental health? Try out the beta version of HealingChat, HealingMaps AI chatbot that takes all our vetted content, clinics and retreats to answer all your questions in a safe environment. Try the beta version now!
Interested in joining a Psychedelics Clinical Trial?Sign up here now and we will connect you with a clinical trial in your area when one becomes available.
The clinic’s highly trained staff is advised by Dr. Glen Brooks, one of the world’s leading experts on the use of ketamine for mental health disorders. The NYKET Center Europe is led by the highly talented Dr. José Miguel Goana. He and the compassionate and experienced team at the clinic understand just how debilitating depression can be.
Their main goal is to help patients heal in a lasting way so they can regain control over their health. By combining cutting-edge science with traditional forms of care, the center hopes to give patients lasting results through the use of ketamine therapy.
Offered Treatments
IV Ketamine Infusion Therapy
Treated Conditions
Depression
Important Info
Online scheduling is available.
How Does Ketamine IV Infusion Work?
Ketamine IV infusion therapy is the most common form of ketamine treatment. The drug is administered directly into the bloodstream through an intravenous drip into the arm. During the treatment, the patient lies still in a calm setting. The effect is usually immediate and can last weeks.
How Many Sessions Does it Typically Take?
Patients typically receive a series of six infusions over two to three weeks. Most treatments last, on average, two hours. This is what’s called the “induction phase” of the treatment. A doctor monitors the patient’s response to the treatment. The patient stops treatment if the first phase is not effective. The patient moves onto the “maintenance phase” if he or she shows signs of improvement. At this stage patients typically return for one infusion every two to six weeks. At this point, the treatment can last as long as the patient desires and shows improvement.
The Healing Maps Editorial Team has decades of experience across all facets of the psychedelic industry. From assessing studies and clinic research, to working with clinician's and clinics, we help provide data-backed information to psychedelic-curious individuals across the globe.
Leave a Reply